LivaNova PLC (NASDAQ:LIVN)‘s stock had its “buy” rating reaffirmed by equities research analysts at Piper Jaffray Companies in a report issued on Friday. They presently have a $85.00 target price on the stock. Piper Jaffray Companies’ price objective indicates a potential upside of 3.96% from the company’s previous close.

A number of other analysts have also recently issued reports on LIVN. Needham & Company LLC lifted their target price on shares of LivaNova PLC from $83.00 to $89.00 and gave the company a “buy” rating in a research note on Friday. Jefferies Group LLC boosted their price objective on shares of LivaNova PLC from $80.00 to $91.00 and gave the stock a “buy” rating in a research note on Friday. Berenberg Bank restated a “buy” rating and issued a $70.00 price objective on shares of LivaNova PLC in a research note on Friday, August 11th. Canaccord Genuity restated a “hold” rating and issued a $71.00 price objective on shares of LivaNova PLC in a research note on Wednesday, September 20th. Finally, WBB Securities cut shares of LivaNova PLC from a “hold” rating to a “sell” rating and set a $50.00 price objective for the company. in a research note on Tuesday, August 15th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and five have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $76.00.

Shares of LivaNova PLC (LIVN) traded up $8.58 on Friday, reaching $81.76. 781,883 shares of the company were exchanged, compared to its average volume of 402,811. The company has a quick ratio of 1.36, a current ratio of 2.03 and a debt-to-equity ratio of 0.04. The stock has a market capitalization of $3.76 billion, a PE ratio of 22.50, a P/E/G ratio of 2.34 and a beta of 0.52.

LivaNova PLC (NASDAQ:LIVN) last announced its quarterly earnings data on Thursday, November 2nd. The company reported $0.93 EPS for the quarter, beating the Zacks’ consensus estimate of $0.76 by $0.17. The firm had revenue of $309.70 million for the quarter, compared to the consensus estimate of $301.22 million. LivaNova PLC had a net margin of 4.63% and a return on equity of 9.33%. The firm’s revenue was up 4.9% on a year-over-year basis. During the same period in the previous year, the firm posted $0.78 earnings per share. equities research analysts forecast that LivaNova PLC will post 3.33 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “LivaNova PLC’s (LIVN) “Buy” Rating Reiterated at Piper Jaffray Companies” was reported by American Banking News and is the property of of American Banking News. If you are reading this story on another publication, it was stolen and republished in violation of international copyright legislation. The correct version of this story can be viewed at https://www.americanbankingnews.com/2017/11/03/livanova-plcs-livn-buy-rating-reiterated-at-piper-jaffray-companies.html.

In other LivaNova PLC news, Director Daniel Jeffrey Moore sold 1,000 shares of the business’s stock in a transaction on Monday, October 16th. The shares were sold at an average price of $74.58, for a total value of $74,580.00. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Over the last quarter, insiders have sold 3,000 shares of company stock valued at $203,890. Corporate insiders own 0.28% of the company’s stock.

A number of institutional investors have recently made changes to their positions in LIVN. BlackRock Inc. increased its holdings in LivaNova PLC by 16,157.4% in the 1st quarter. BlackRock Inc. now owns 2,592,889 shares of the company’s stock valued at $127,077,000 after buying an additional 2,576,940 shares during the period. Koch Industries Inc. bought a new stake in LivaNova PLC in the 2nd quarter valued at $1,384,000. State Street Corp increased its holdings in LivaNova PLC by 74.8% in the 2nd quarter. State Street Corp now owns 1,835,428 shares of the company’s stock valued at $112,345,000 after buying an additional 785,268 shares during the period. HealthCor Management L.P. bought a new stake in LivaNova PLC in the 2nd quarter valued at $24,484,000. Finally, Franklin Resources Inc. increased its holdings in LivaNova PLC by 7.5% in the 2nd quarter. Franklin Resources Inc. now owns 5,089,070 shares of the company’s stock valued at $311,515,000 after buying an additional 354,956 shares during the period. 82.28% of the stock is currently owned by hedge funds and other institutional investors.

LivaNova PLC Company Profile

LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.

Analyst Recommendations for LivaNova PLC (NASDAQ:LIVN)

Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with MarketBeat.com's FREE daily email newsletter.